Lightcalls.com
 

FACTS currency ... corporate soci...

FACTS currency

... corporate social responsibility is not about what you give, it's about by what mode you operate

A social investor's view

With the breakdown in investor confidence in financial reporting, companies are facing increasing influence from shareholders, employees, suppliers, and other stakeholders to be more accountable for their actions. Today, all investors are interested about potential, undisclosed liabilities. The Enron fiasco has taught us that relying upon company management and boards of directors to provide adequate oversight and exercise fiduciary responsibility may be expecting too a great quantity [i]or[/i] amount of The spillover demonstrates that companies take a hit when their ethical risk management a whole s fail.

If you had asked someone what the expression "business ethics" meant ten years ago, they would have be agreeable toed with a blank stare. The unfathomable thinkers would probably have dismissed the universal as an oxymoron-like "jumbo shrimp." Right now, most numerous companies tell us a hazard about their philanthropic activities. nevertheless corporate social responsibility is not about what you give, it's about for what reason you operate.

Traditionally, commentators described an ethical company as undivided that obeyed the law or implemented a business digest of conduct. In May 1999 an Environics individual found that 88% of Canadians reflection the role of large corporations in society amounted to more than making a profit, paying taxes, creating piece of works and obeying all laws. This answer rate was second only to that of Australia among the 23 countries for which the individual was conducted.



And more newly in a 2001 opinion catalogue of heads Vector Research found that 72% of Canadians (and 74% of those holding shares) count upon businesses to pursue social responsibilities, not just profits. In the same catalogue of heads 51% of respondents (and 54% of those holding shares) indicated they would pick out a pension plan that invested in companies with a profitable record of social responsibility, unruffled if it resulted in somewhat lower benefits to themselves. These attitudes describe the evolution of business ethics into a broader and more meaningful general [i]or[/i] abstract notion of corporate social responsibility.

We know that hardy social and environmental performance leads to capable financial performance. A study bearinged by Innovest Strategic Value Advisers and Q International showed that applying environmental screening criteria can create substantially higher recurs for investors. An equally weighted portfolio of Innovest's top-ranked companies outperformed an equally weighted portfolio of all companies tracked according to Innovest by 3.13% on an annualized basis for the five years ending December 31 2001 In the principally environmentally sensitive industries, top-ranked stocks outperformed bottom-ranked stocks at 5.49% on an annualized basis for the five years ending December 31 2001

Empirical evidence like this is changing the way the investment community perceives company performance. In a examine of European financial experts, 51% of portfolio managers and 37% of financial analysts indicated that they explicitly recognize the value of social responsibility at granting a premium to those companies that demonstrate corporate social responsibility. And 86% of the adroits said they believed that social and environmental risk management added to a company's market performance in the lengthy term.

It's just everyday sense. Companies that treat their employee well will be more productive athwart time. Companies with progressive environmental policies won't have to pay enormous environmental fines or take forward legal liabilities. Companies with progressive international operations will have widespread consumer support for their cropss And companies that are transparent and accountable will inspire confidence in their balance sheets. on the contrary the bottom line is that companies that focus forward social and environmental performance are more innovative, which makes them better able to manage their businesses in the midst of this complicate and changing environment.

We know that corporate responsibility doesn't just mean philanthropy or environmental sustainability. It's a broader general [i]or[/i] abstract notion that evaluates companies for transparency, fairness, accountability, and integrity. Transparency for reporting is the first stair Because, as we all learned this past year, if a company doesn't have reliable reporting regularitys and verifiable data then things can go on badly awry. Companies must have policies and practices in place that allow others to evaluate their risk management a whole s vis-a-vis social, environmental, and ethical liabilities.

How do companies address these emerging standards for social and environmental reporting?

The triple bottom line approach is a proactive answer to questions raised at investors concerned with increased transparency and accountability. Companies that measure their performance according to economic, environmental, and social performance are simply practicing cutting-edge risk management.

The Global Reporting Initiative & sustainability

The Global Reporting Initiative (GRI) is an independent global institution that is developing a generally accepted framework for sustainability reporting. The aim of the GRI guidelines is to enable companies and other organizations to prepare comparable "triple bottom line" reports. The close goal of the GRI is to make sustainability reporting as routine and credible as financial reporting in word s of comparability, rigour, and verifiability.



Other Articles
 -Morphotek will collaborat...
 -Eksigent Technologies nam...
 -The benefits of outsourci...
 -Sartorius Corporation ...
 -In our previous column, w...
 -Efoora appointed Michael ...
 -Affymax appointed Anne-Ma...
 -Traditionally, continuous...
 -New Brunswick Scientific ...
 -The German-American firm ...
 -Don G. Burstyn, formerly ...
 -American patients are mor...
 -Summary Prior to va...
 -BioPharm Editorial Adviso...
 -Australia agreed to spend...
 -The Biotechnology Industr...
 -Ambion, The RNA Company i...
 -Therapies based on living...
 -A recent survey found tha...
 -ViroLogic will acquire Ac...
 -Cardinal Health named Joh...
 -One of the greatest chall...
 -As the president of a sma...
 -Sweden-based Biovitrum wi...
 -Nanogen appointed David L...
 -The Experion Process Know...
 -Although biomedical resea...
 -The Supreme Court of Cana...
 -Netherlands-based DSM Bio...
 -David A. Smoller joined S...
 -A few months ago, I wrote...
 -Panacos Pharmaceuticals w...
 -Karen K. Vaccaro will res...
 -Acceleron Pharma appointe...
 -Two quarterly meetings of...
 -Illinois-based Abbot Labo...
 -FKI Logistics announced t...
 -The following corrections...
 -It its widest definition,...
 -UK-based Xcellsyz will li...
 -Andrew P. Aromando joined...
 -Invitrogen's comprehensiv...
 -Last month, we described ...
 -The Swiss life sciences c...
 -Protein Design Labs (PDL)...
 -Model It HNMR, the newest...
 -Tech transfer, like chang...
 -QLT and Atrix Laboratorie...
 -Dendreon announced Christ...
 -Baxter Pharmaceutical Sol...
 -The biopharmaceutical ind...
 -GlaxoSmithKline announced...
 -Montreal-based Caprion Ph...
 -Xenova Group recently ann...
 -Cole-Parmer's new 192-pag...
 -Over the last decade ther...
 -Benchmark your facility p...
 -As biotechnology organiza...
 -Frederick D. Sancillo, fo...
 -Insmed acquired a recombi...
 -Baxter Pharmaceutical Sol...
 -Model It HNMR, the newest...
 -DA's regulation 21 CFR Pa...
 -Robert P. Ryan joined Ath...
 -A new report from Busines...
 -Biotest offers a complete...
 -Swagelok offers a brochur...
 -Partnering is a global ph...
 -Human Genome Sciences CEO...
 -Shorten the process devel...
 -The licensure of biotechn...
 -Rodger Currie joined Amge...
 -The GEA Filtration Model ...
 -A multi-channel chemistry...
 -From June 6-9, San Franci...
 -Skanska USA Building Inc....
 -New Brunswick Scientific'...
 -AVI BioPharma appointed P...
 -Ambion, The RNA Company, ...
 -"If you want to be a...
 -Xcellerex appointed Susan...
 -Researchers identified th...
 -Cool Spring Business Park...
 -In October 2003, Shenzhen...
 -Laureate Pharma appointed...
 -After a 6-5 vote by Calif...
 -QSourcing, a service of Q...
 -The recent discovery of &...
 -Affymax added Douglas L. ...
 -USDA recently approved tw...
 -BioPharm International is...
 -Serologicals has released...
 -This document by Shenzhen...
 -Robert Bronstein joined A...
 -Gloucester Gains Fujisawa...
 -With more than 30 years o...
 -Pall's SUPRAdisc II depth...
 -In today's competitive ma...
 -Protein Design Labs repor...
 -Charles A. Rice will repl...
 -AstraZeneca's Faslodex (f...
.
© 2006 Lightcalls.com All rights reserved.